Meek David D. 4
4 · Mirati Therapeutics, Inc. · Filed Jan 24, 2023
Insider Transaction Report
Form 4
Meek David D.
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2023-01-20+151,233→ 151,233 totalExercise: $45.66Exp: 2033-01-20→ Common Stock (151,233 underlying) - Award
Common Stock
2023-01-20+89,379→ 151,171 total
Footnotes (2)
- [F1]Grant of Restricted Stock Units (RSUs). Shares will vest 25% annually on the anniversary of the grant date until fully vested.
- [F2]25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.